Richard I Steinhart's Net Worth
$551 Thousand
Who is Richard I Steinhart?
Richard I Steinhart does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MANHATTAN PHARMACEUTICALS INC, BioXcel Therapeutics, Inc., Actinium Pharmaceuticals, Inc., MELA SCIENCES, INC. /NY, and ATOSSA THERAPEUTICS, INC..
SEC CIK
Richard I Steinhart's CIK is 0001293789
Past Insider Trading and Trends
2018 was Richard I Steinhart's most active year for acquiring shares with 9 total transactions. Richard I Steinhart's most active month to acquire stocks was the month of February. 2023 was Richard I Steinhart's most active year for disposing of shares, totalling 7 transactions. Richard I Steinhart's most active month to dispose stocks was the month of February. 2013 saw Richard I Steinhart paying a total of $337,092.00 for 235,754 shares, this is the most they've acquired in one year. In 2021 Richard I Steinhart cashed out on 7,500 shares for a total of $180,562.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MANHATTAN PHARMACEUTICALS INC (TGTX) Snapshot price: $22.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
∞
| 5.63K |
—
|
—
| 5.63K |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BioXcel Therapeutics, Inc. (BTAI) Snapshot price: $0.511
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.29% | 728 |
$0.69 | -$245.60 | 6.2K |
Scheduled
|
Sep 14 - Sep 16
| ||
Form 4
| +14.92% | 711 |
$1.26 | -$469.54 | 5.48K |
Scheduled
|
Jun 14 - Jun 17
| ||
Form 4
| +55.57% | 1.7K |
$2.64 | -$2,816.81 | 4.76K |
Scheduled
|
Mar 14 - Apr 4
| ||
Form 4
| +20.50% | 521 |
—
|
—
| 3.06K |
Dec 14
| |||
Form 4
| +25.78% | 521 |
—
|
—
| 2.54K |
Sep 14
| |||
Form 4
| +34.73% | 521 |
—
|
—
| 2.02K |
Jun 14
| |||
Form 4
|
—
|
0
|
$27.17 | -$135,863.50 | 1.5K |
May 14 - May 15
| |||
Form 4
|
—
|
0
|
$19.50 | -$40,638.00 | 1.5K |
Scheduled
|
Mar 14 - Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
$26.85 | -$159,750.00 | 1.5K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +50.00% | 500 |
$5.20 | $2,599.95 | 1.5K |
Dec 3
| |||
Form 4
| +100.00% | 500 |
$5.00 | $2,500.00 | 1K |
Nov 30
| |||
Form 4
|
∞
| 500 |
$5.00 | $2,500.00 | 500 |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $1.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
| +280.00% | 7K |
$0.50 | $3,500.00 | 9.5K |
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
∞
| 2.5K |
$2.01 | $5,025.00 | 2.5K |
Apr 14 - Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MELA SCIENCES, INC. /NY (SSKN) Snapshot price: $3
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Aug 5
| |||
Form 4
| +300.00% | 3K |
$0.81 | $2,427.00 | 4K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
∞
| 1K |
$6.32 | $6,320.00 | 1K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ATOSSA THERAPEUTICS, INC. (ATOS) Snapshot price: $1.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| -100.00% | -22.73K |
—
|
—
|
0
|
May 6
| |||
Form 4
|
∞
| 22.73K |
—
|
—
| 22.73K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||